Literature DB >> 2541714

Induction of differentiation of human monoblastic and myeloblastic leukemia cell lines by TNF muteins.

R Kamijo1, K Takeda, M Nagumo, K Konno, A Hasegawa, K Inaka, M Ikehara.   

Abstract

The differentiation inducing activity of five recombinant human tumor necrosis factor (rHuTNF) muteins, prepared by protein engineering techniques, was compared by measuring the ability to reduce nitroblue tetrazolium dye of human myelogenous leukemia cells. TNF(C-Phe), in which the C-terminal leucine of TNF molecule was replaced by phenylalanine, was 20-times as potent in induction of differentiation of U-937 cells as the parent TNF(N-Met), in which methionine was added to N-terminal sequence of TNF. The differentiation inducing activity of TNF muteins was not always proportional to their binding activity to the receptors nor to their cytotoxicity on U-937 cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541714     DOI: 10.1016/0006-291x(89)92507-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Safety evaluation and pharmacokinetics of a novel human tumor necrosis factor-alpha exhibited a higher antitumor activity and a lower systemic toxicity.

Authors:  Meng Li; Xin Qin; Xiaochang Xue; Cun Zhang; Zhen Yan; Wei Han; Chris Komarck; Thomas D Wang; Yingqi Zhang
Journal:  Anticancer Drugs       Date:  2010-03       Impact factor: 2.248

2.  The effect of chemotherapy combined with recombination mutant human tumor necrosis factor on advanced cancer.

Authors:  Xing Liu; Xiang-Fu Zhang; Zhi-Weng Zheng; Huishan Lu; Xinyuan Wu; Changmin Huang; Chuan Wang; Guoxiang Guang
Journal:  J Transl Med       Date:  2004-10-14       Impact factor: 5.531

3.  A novel recombinant slow-release TNF α-derived peptide effectively inhibits tumor growth and angiogensis.

Authors:  Yi Ma; Shaojun Zhao; Shutao Shen; Shixiong Fang; Zulu Ye; Zhi Shi; An Hong
Journal:  Sci Rep       Date:  2015-09-04       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.